RxDoctor Payments Data

Spencer Voth, DO

Otolaryngology · Tulsa, OKNPI 1639487499

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,813 of the $2,810 with a category attached, or 64.5%. 20 manufacturers reported payments, led by Med-el Corporation at 38.2% of the total. Reporting peaked in 2019 at $1,564 and has fallen 84.9% since, to $236 in 2025.

$2,810in general payments, 2019–2025

Across 60 payments — averaging $46.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$1K
  • Inspire Medical Systems, Inc.$424
  • Intersect ENT, Inc.$269
  • Aerin Medical Inc.$146
  • Stryker$126
  • Regeneron Healthcare Solutions, Inc.$107
  • plus $666 from 14 others

What the payments were for

  • Travel & lodging$99835%
  • Food & beverage$1,81365%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,810 in reported general payments places this provider in the 70th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$115,075
Medicare patients
323
Services billed
746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth27$2,952
Fluticasone Propionate114$1,320
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen73$636
Ofloxacin41$626
Azelastine Hcl21$508
Ipratropium Bromide22$481
Cephalexin78$383
Clindamycin Hcl12$155
Ondansetron Hcl50$155
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$147
Ondansetron OdtOndansetron15$94
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid19$56

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →